Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CytomX Therapeutics Inc.

    NASDAQ: CTMX · Real-Time Price · USD
    2.13
    0.22 (11.52%)
    At close: Aug 18, 2025, 3:59 PM
    2.10
    -1.18%
    Pre-market: Aug 19, 2025, 04:06 AM EDT

    CytomX Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 31.87M -569K -99.32M -83.61M
    Depreciation & Amortization
    		 146K 2.17M 2.44M 2.71M
    Stock-Based Compensation
    		 7.67M 8.56M 13.13M 13.17M
    Other Working Capital
    		 -126.45M -93.64M 4.47M -66.21M
    Other Non-Cash Items
    		 -1.12M -3.69M 3.62M 3.13M
    Deferred Income Tax
    		 n/a n/a n/a 272K
    Change in Working Capital
    		 -126.42M -62.51M -30.65M -54.7M
    Operating Cash Flow
    		 -86.23M -56.03M -110.79M -119.03M
    Capital Expenditures
    		 -310K -840K -1.74M -1.61M
    Cash Acquisitions
    		 n/a n/a n/a -24.1M
    Purchase of Investments
    		 -155.49M -424.83M n/a -99.9M
    Sales Maturities Of Investments
    		 255.5M 275M 100M 124M
    Other Investing Acitivies
    		 n/a n/a 100M 24.1M
    Investing Cash Flow
    		 99.7M -150.67M 98.26M 22.49M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 613K 30.23M 648K 2.5M
    Financial Cash Flow
    		 7.52M 30.23M 648K 110.21M
    Net Cash Flow
    		 20.99M -176.48M -11.88M 13.67M
    Free Cash Flow
    		 -86.54M -56.88M -112.53M -120.64M

    Add to Watchlist